The story of Sildenafil presents a complex picture for investors. While the initial introduction generated massive gains, the lapse of its patent opened the door to off-brand alternatives, dramatically reducing https://karimswfx553613.idblogz.com/42154413/sildenafil-and-the-pharmaceutical-industry-a-precarious-opportunity